Advanced search×

Seminars in Nuclear Medicine

Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Gale, Sciencedirect from 1971, Proquest, and CSA

  1. Perspectives in molecular imaging through translational research, human medicine, and veterinary medicine.

    Seminars in Nuclear Medicine 44(1):66 (2014) PMID 24314047

    The concept of molecular imaging has taken off over the past 15 years to the point of the renaming of the Society of Nuclear Medicine (Society of Nuclear Medicine and Molecular Imaging) and Journals (European Journal of Nuclear Medicine and Molecular Imaging) and offering of medical fellowships spec...
  2. PET/CT imaging of inflammatory bowel disease.

    Seminars in Nuclear Medicine 43(6):420 (2013) PMID 24094709

    PET/CT imaging has become an important part of the evaluation of patients with many types of cancer. This imaging modality can also be used to image areas of active inflammation, such as those occurring in patients with active inflammatory bowel disease (IBD) (Crohn's disease and ulcerative colitis)...
  3. Letter from the editors.

    Seminars in Nuclear Medicine 43(3):157 (2013) PMID 23561450

  4. Positron emission tomography in renal cell carcinoma: an imaging biomarker in development.

    Seminars in Nuclear Medicine 42(4):221 (2012) PMID 22681671

    We will start with a brief overview of the demographics, molecular pathogenesis, and evolving treatment strategies in RCC because this information is essential for better understanding of uptake of various PET radiotracers in this cancer and their indications. This will be followed by discussing the...
  5. Decreased sensitivity of (18)F-fluorodeoxyglucose imaging in infection and inflammation.

    Seminars in Nuclear Medicine 42(4):261 (2012) PMID 22681675

    Nuclear medicine plays an important role in the evaluation of inflammation and infection. Although (99m)Tc-methylene diphosphonate, (67)Ga-citrate, and in vitro labeled autologous leukocyte imaging are useful procedures, there are limitations to each of them. (18)F-fluorodeoxyglucose-positron-emissi...
  6. Concepts, consequences, and implications of theranosis.

    Seminars in Nuclear Medicine 42(3):147 (2012) PMID 22475423

    Although the term has been coined recently, the concepts underlying theranosis have been applied in patient care for more than one-half century. However, advanced technologies are used now. Theranosis describes processes used to tailor therapy for a patient. It is the use of diagnostic tests to iden...
  7. In Memoriam: Alexander Gottschalk, MD (1932-2010)

    Seminars in Nuclear Medicine 41(2):2 (2011) PMID 21272680

  8. Design of Clinical Trials

    Seminars in Nuclear Medicine 40(5):6 (2010) PMID 20674592

    Clinical trial design for nuclear medicine diagnostic imaging radiopharmaceuticals must include a design for preclinical safety studies. These studies should establish that the investigational product (IP) does not have a toxic effect. As a further requirement, radiopharmaceutical cl...
  9. Immuno-positron emission tomography in cancer models.

    Seminars in Nuclear Medicine 40(3):182 (2010) PMID 20350627 PMCID PMC2848398

    Positron emission tomography (PET) is playing an increasingly important role in the diagnosis, staging, and monitoring response to treatment in a variety of cancers. Recent efforts have focused on immuno-PET, which uses antibody-based radiotracers, to image tumors based on expression of tumor-associ...
  10. Seminars in Nuclear Medicine. Selected pharmacologic interventions and monitoring. Letter from the editors.

    Seminars in Nuclear Medicine 39(3):155 (2009) PMID 19341835